{"id":55987,"date":"2023-04-19T12:04:58","date_gmt":"2023-04-19T10:04:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/"},"modified":"2023-04-19T12:04:58","modified_gmt":"2023-04-19T10:04:58","slug":"global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/","title":{"rendered":"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5767141\/hepatic-encephalopathy-therapeutics-market-size?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=m8s4rg&amp;utm_campaign=1842005+-+Global+Hepatic+Encephalopathy+Therapeutics+Market+Report+2023%3A+Players+Include+Mallinckrodt+Pharmaceuticals%2C+Salix+Pharmaceuticals%2C+GlaxoSmithKline+and+Pfizer&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Hepatic Encephalopathy Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230419005559\/en\/1768120\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230419005559\/en\/1768120\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global hepatic encephalopathy therapeutics market is projected to expand at a CAGR Of 6.5% between 2023 and 2031.<\/p>\n<p>\n<strong>Companies Mentioned<\/strong><\/p>\n<ul>\n<li>\nMallinckrodt Pharmaceuticals<\/li>\n<li>\nSalix Pharmaceuticals<\/li>\n<li>\nGlaxoSmithKline plc.<\/li>\n<li>\nPfizer Inc.<\/li>\n<li>\nASKA Pharmaceutical Co. Ltd.<\/li>\n<li>\nBausch Health<\/li>\n<li>\nJohnson &amp; Johnson Services Inc.<\/li>\n<li>\nJanssen Global Services<\/li>\n<li>\nTakeda Pharmaceutical Company Limited<\/li>\n<li>\nMerck &amp; Co. Inc.<\/li>\n<\/ul>\n<p>\nAs per the citing of the National Organization for Rare Diseases (NORD) 2016 report, hepatic encephalopathy is described as a brain disorder in patients previously suffering from chronic liver ailments such as liver cirrhosis, hepatitis, and acute liver failure. If effectively diagnosed, hepatic encephalopathy occurs in almost two-thirds of the patients suffering from liver cirrhosis.<\/p>\n<p>\nHepatic encephalopathy is categorized into 3 types Type A (acute liver failure), Type B (portal systemic bypass without liver disease), and Type C (liver cirrhosis). The exact disease etiology is unknown but the disease is triggered by the accumulation of toxins in the bloodstream as the diseased liver fails to neutralize the toxins.<\/p>\n<p>\nThe clinical manifestation associated with hepatic encephalopathy is confusion, anxiety, lethargy, seizures, confused speech, personality changes, and poor body movements. The key factors driving the hepatic encephalopathy therapeutics market are the rising prevalence of liver disorders, lack of nutrients in daily food intake, and increasing public health awareness resulting in early diagnosis and treatment.<\/p>\n<p>\nThe diagnosis of hepatic encephalopathy includes blood tests, liver function tests, detection of serum ammonia levels, and an encephalogram of the brain to measure the electrical activity of the brain. There are numerous therapeutic approaches to manage the severity of hepatic encephalopathy, but the reduction of plasma ammonia is the most preferred strategy. Lactulose is the first line of treatment as it changes the acidity of the stool to reduce the production of ammonia by killing intestinal bacteria.<\/p>\n<p>\nProbiotics and thiamine are useful in the treatment of hepatic encephalopathy by increasing the expulsion of ammonia genic bacteria by causing the bowel to get fermented by colonic bacteria to produce lactic and acetic acid. In 2010 the USFDA approved Rifaximin for the treatment of hepatic encephalopathy by acting on the microorganisms in the intestinal tract producing ammonia.<\/p>\n<p>\n<strong>Historical &amp; Forecast Period<\/strong><\/p>\n<p>\nThis study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.<\/p>\n<p>\n<strong>Market Segmentation<\/strong><\/p>\n<p>\n<strong>Drug Class<\/strong><\/p>\n<ul>\n<li>\nAntibiotics<\/li>\n<li>\nLaxatives<\/li>\n<li>\nL-ornithine<\/li>\n<li>\nL-aspartate<\/li>\n<\/ul>\n<p>\n<strong>Diagnosis<\/strong><\/p>\n<ul>\n<li>\nBlood Tests<\/li>\n<li>\nCT Scan<\/li>\n<li>\nLiver Functioning Tests<\/li>\n<\/ul>\n<p>\n<strong>Route of Administration<\/strong><\/p>\n<ul>\n<li>\nOral<\/li>\n<li>\nInjectable<\/li>\n<li>\nIntravenous<\/li>\n<li>\nOthers<\/li>\n<\/ul>\n<p>\n<strong>Distribution Channel<\/strong><\/p>\n<ul>\n<li>\nHospital Pharmacy<\/li>\n<li>\nOnline Pharmacy<\/li>\n<li>\nRetail Pharmacy<\/li>\n<\/ul>\n<p>\n<strong>Key questions answered in this report<\/strong><\/p>\n<ul>\n<li>\nWhat are the key micro and macro environmental factors that are impacting the growth of the Hepatic Encephalopathy Therapeutics market?<\/li>\n<li>\nWhat are the key investment pockets with respect to product segments and geographies currently and during the forecast period?<\/li>\n<li>\nEstimated forecast and market projections up to 2031.<\/li>\n<li>\nWhich segment accounts for the fastest CAGR during the forecast period?<\/li>\n<li>\nWhich market segment holds a larger market share and why?<\/li>\n<li>\nAre low and middle-income economies investing in the Hepatic Encephalopathy Therapeutics market?<\/li>\n<li>\nWhich is the largest regional market for the Hepatic Encephalopathy Therapeutics market?<\/li>\n<li>\nWhat are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East &amp; Africa?<\/li>\n<li>\nWhich are the key trends driving the Hepatic Encephalopathy Therapeutics market growth?<\/li>\n<li>\nWho are the key competitors and what are their key strategies to enhance their market presence in the Hepatic Encephalopathy Therapeutics market worldwide?<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5767141\/hepatic-encephalopathy-therapeutics-market-size?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=m8s4rg&amp;utm_campaign=1842005+-+Global+Hepatic+Encephalopathy+Therapeutics+Market+Report+2023%3A+Players+Include+Mallinckrodt+Pharmaceuticals%2C+Salix+Pharmaceuticals%2C+GlaxoSmithKline+and+Pfizer&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/qfdwza<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#112;r&#x65;&#115;s&#x40;&#114;e&#x73;&#101;a&#x72;&#99;h&#x61;&#110;d&#x6d;&#97;r&#x6b;&#101;t&#x73;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;e&#x73;&#115;&#64;&#x72;&#101;s&#x65;&#x61;&#114;&#x63;&#x68;&#97;n&#x64;&#109;a&#x72;&#107;e&#x74;&#x73;&#46;&#x63;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hepatic Encephalopathy Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hepatic encephalopathy therapeutics market is projected to expand at a CAGR Of 6.5% between 2023 and 2031. Companies Mentioned Mallinckrodt Pharmaceuticals Salix &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55987","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hepatic Encephalopathy Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hepatic encephalopathy therapeutics market is projected to expand at a CAGR Of 6.5% between 2023 and 2031. Companies Mentioned Mallinckrodt Pharmaceuticals Salix ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-19T10:04:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230419005559\/en\/1768120\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-04-19T10:04:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/\"},\"wordCount\":710,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230419005559\\\/en\\\/1768120\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/\",\"name\":\"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230419005559\\\/en\\\/1768120\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-04-19T10:04:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230419005559\\\/en\\\/1768120\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230419005559\\\/en\\\/1768120\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hepatic Encephalopathy Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hepatic encephalopathy therapeutics market is projected to expand at a CAGR Of 6.5% between 2023 and 2031. Companies Mentioned Mallinckrodt Pharmaceuticals Salix ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-19T10:04:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230419005559\/en\/1768120\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer &#8211; ResearchAndMarkets.com","datePublished":"2023-04-19T10:04:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/"},"wordCount":710,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230419005559\/en\/1768120\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/","name":"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230419005559\/en\/1768120\/21\/logo.jpg","datePublished":"2023-04-19T10:04:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230419005559\/en\/1768120\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230419005559\/en\/1768120\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-hepatic-encephalopathy-therapeutics-market-report-2023-players-include-mallinckrodt-pharmaceuticals-salix-pharmaceuticals-glaxosmithkline-and-pfizer-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55987"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55987\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}